Treating Hepatitis C Virus Infection in Patients With Decompensated Cirrhosis: Who, How, and Why

Assessment of Needs

The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians.

Learning Objectives

At the conclusion of this webinar, learners will be able to:

• Discuss the treatment of HCV in patients with decompensated cirrhosis

Registration

Who Should Attend

This webinar is designed for clinical decision makers, such as physicians, nurse practitioners and physician assistants, who have a good understanding of the basics of HCV transmission, testing, and management, and have managed HCV infection in at least 5 patients.

This activity is also relevant for registered nurses, PharmDs, and other health professionals.

Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a certificate of participation.

Registration closes on Wednesday, September 20, 2017, 4:00 PM (PT).

Certificates will be available after the completion of the evaluation and claim form.

For more information or questions, please contact the registration department at registration@iasusa.org or 415-544-9400.

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.